Overview

Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA)

Status:
Completed
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of DHP1401 in patients with mild-moderate Alzheimer's disease treated with donepezil
Phase:
Phase 2
Details
Lead Sponsor:
Daehwa Pharmaceutical Co., Ltd.
Treatments:
Donepezil